Coming soon on demand.
Peptides are rapidly emerging as one of the most promising frontiers in nutrition and wellness innovation. Advances in precision fermentation, bioinformatics, protein hydrolysis, and AI-enabled peptide discovery are accelerating the development of next-generation peptide ingredients for healthy aging, muscle health, cognition, metabolic wellness, gut health, and more.
As interest in peptide-based solutions continues to grow, this webinar will explore the evolving science behind bioactive peptides, translational opportunities for dietary supplements, and the regulatory and commercialization considerations shaping the future of peptide-based nutrition products.
Hear from:
Ashish Talati, Member, Talati Law
Ashish R. Talati is one of the industry’s foremost experts on FDA regulatory matters. Ashish primarily counsels clients on matters of regulatory compliance, helping them anticipate and address regulatory issues in their day-to-day business operations and strategic planning. He is considered a leading authority in the areas of Generally Recognized as Safe (GRAS) requirements and New Dietary Ingredients (NDI). Considered a creative and strategic partner by his clients, Ashish works with companies all over the globe and is a trusted advisor at every step of the product life cycle, including product formulation, safety and efficacy studies, product launch, and ongoing marketing and sales.
Michael Anthonavage is Vice President of Product Development and Innovation at Vitaquest International, where he leads strategic innovation initiatives that drive growth, product differentiation, and quality across the nutraceutical industry. With more than 25 years of experience spanning consumer health, nutraceuticals, personal care, and clinical research, he has built a career translating scientific advances into successful commercial solutions.
Prior to joining Vitaquest, Michael served as Vice President of Operations & Technology at Eurofins Clinical Research Laboratories and held senior scientific and technology leadership roles at Johnson & Johnson Consumer Products as well as at a variety of technology suppliers such as Vantage Specialty Chemicals and Presperse. Michael is also a member of and chair of the NYSCC Scientific Committee. Throughout his career, he has led innovation pipelines, technology platforms, operational excellence initiatives, and strategic partnerships across global organizations.
A frequent industry speaker, educator, published author, and named inventor on multiple patents, Michael is recognized for connecting scientific rigor with business strategy. He holds advanced degrees in biology and is ASCP certified.
Nora Khaldi, CEO and Founder, Nuritas
Dr. Nora Khaldi is the Founder and CEO of Nuritas, a biotechnology company that combines AI and molecular biology to discover bioactive peptides from natural food sources. She founded Nuritas with the vision of impacting billions of lives by accelerating the discovery of clinically proven ingredients that improve human health. Using its proprietary platform, The Magnifier, the company identifies smart peptides hidden in nature and partners with leading global brands to bring science-backed solutions to consumers worldwide, supporting areas such as sleep, strength, recovery, and metabolic health.
Moderated by Haiuyen Nguyen, VP, Regulatory & Nutrition Policy, CRN
Ms. Nguyen provides analysis and strategies for accomplishing CRN’s scientific and regulatory objectives, including CRN’s Science in Session event and targeted activities of the Regulatory Affairs Committee and Senior Scientific Advisory Council. She is involved in developing CRN’s regulatory and scientific comments on dietary supplement‒related topics submitted to federal agencies including the U.S. Food and Drug Administration and Department of Health and Human Services. Her responsibilities include handling external relations for several of CRN’s self-regulatory coalitions and projects. She earned her B.S. in cellular and molecular biology and genetics from the University of Maryland, College Park.
Who should attend?
- R&D executives and directors of product innovation
- Scientific affairs directors
- Regulatory affairs directors
- Marketing directors
- Technical sales directors
- Industry professionals involved in product development and commercialization
$149 for CRN members / $249 for non-members
